Cite
HARVARD Citation
Van Damme, H. et al. (2021). Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy. Journal for immunotherapy of cancer. 9 (2), p. . [Online].